Evangelos D Michelakis (Evangelos Michelakis)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 10

Top Topics

Chronic Lymphocytic Leukemia

Pulmonary Arterial Hypertension

Top Venues

Circulation research

Science translational medicine

Journal of molecular medicine (Berlin, Germany)

American journal of respiratory and critical care medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Areli Lorenzana-Carrillo, Saymon Tejay, Joseph Nanoa, Guocheng Huang, Yongsheng Liu, Alois Haromy, Yuan Yuan Zhao, Michelle Mendiola Pla, Dawn E Bowles, Adam Kinnaird, Evangelos D Michelakis, Gopinath Sutendra
TRIM35 Monoubiquitinates H2B in Cardiac Cells, Implications for Heart Failure. Circulation research 135 (2) (2024)
Maria Areli Lorenzana-Carrillo, Saymon Tejay, Joseph Nanoa, Guocheng Huang, Yongsheng Liu, Alois Haromy, Yuan Yuan Zhao, Michelle Mendiola Pla, Dawn E Bowles, Adam Kinnaird, Evangelos D Michelakis, Gopinath Sutendra
TRIM35 Monoubiquitinates H2B in Cardiac Cells, Implications for Heart Failure. Circulation research 135 (2) (2024)
Maria Areli Lorenzana-Carrillo, Saymon Tejay, Joseph Nanoa, Guocheng Huang, Yongsheng Liu, Alois Haromy, Yuan Yuan Zhao, Michelle Mendiola Pla, Dawn E Bowles, Adam Kinnaird, Evangelos D Michelakis, Gopinath Sutendra
TRIM35 Monoubiquitinates H2B in Cardiac Cells, Implications for Heart Failure. Circulation research (2024)
Maria Areli Lorenzana-Carrillo, Keshav Gopal, Nikole J Byrne, Saymon Tejay, Bruno Saleme, Subhash K Das, Yongneng Zhang, Alois Haromy, Farah Eaton, Michelle Mendiola Pla, Dawn E Bowles, Jason R B Dyck, John R Ussher, Evangelos D Michelakis, Gopinath Sutendra
TRIM35-mediated degradation of nuclear PKM2 destabilizes GATA4/6 and induces P53 in cardiomyocytes to promote heart failure. Science translational medicine 14 (669) (2022)
Alexandra Saunders, Evangelos D Michelakis
Atrial Shunt Devices in Patients With Heart Failure and Preserved or Mildly Reduced Ejection Fraction and the Pulmonary Circulation: Promises and Concerns. Circulation 145 (21) (2022)
Yongneng Zhang, Evangelos D Michelakis
Changing cell fate in the wall of pulmonary arteries. Science translational medicine 14 (643) (2022)
Yongneng Zhang, Evangelos D Michelakis
A Phase-2 NIH-sponsored Randomized Clinical Trial of Rituximab in Scleroderma-associated Pulmonary Arterial Hypertension Did Not Reach Significance for Its Endpoints: End of Story? Not So Fast! American journal of respiratory and critical care medicine 204 (2) (2021)
Yongneng Zhang, Sotirios D Zervopoulos, Aristeidis E Boukouris, Maria Areli Lorenzana-Carrillo, Bruno Saleme, Linda Webster, Yongsheng Liu, Alois Haromy, Seyed Amirhossein Tabatabaei Dakhili, John R Ussher, Gopinath Sutendra, Evangelos D Michelakis
SNPs for Genes Encoding the Mitochondrial Proteins Sirtuin3 and Uncoupling Protein 2 Are Associated With Disease Severity, Type 2 Diabetes, and Outcomes in Patients With Pulmonary Arterial Hypertension and This Is Recapitulated in a New Mouse Model Lacking Both Genes. Journal of the American Heart Association 10 (23) (2021)
Adam Kinnaird, Aristeidis E Boukouris, Bruno Saleme, Peter Dromparis, Sotirios D Zervopoulos, Vikram Gurtu, Gopinath Sutendra, Evangelos D Michelakis
Interaction with p53 explains a pro-proliferative function for VHL in cancer. Journal of molecular medicine (Berlin, Germany) 98 (9) (2020)
Evangelos D Michelakis, Vikram Gurtu, Linda Webster, Gareth Barnes, Geoffrey Watson, Luke S G Howard, John Cupitt, Ian Paterson, Richard B Thompson, Kelvin Chow, Declan P O'Regan, Lan Zhao, John Wharton, David G Kiely, Adam Kinnaird, Aristeidis E Boukouris, Chris White, Jayan Nagendran, Darren H Freed, Stephen J Wort, J Simon R Gibbs, Martin R Wilkins
Inhibition of pyruvate dehydrogenase kinase improves pulmonary arterial hypertension in genetically susceptible patients. Science translational medicine 9 (413) (2018)